Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 14, 2017
Event: Regulation FD Disclosure regarding the posting of a corporate presentation on the Company's website.
Financial Metrics
This filing does not contain specific financial data. The document serves solely to disclose the availability of a corporate presentation (Exhibit 99.1) which updates the Company's current business and products. No revenue, profit, cash flow, margin, debt, or liquidity figures are provided in this text.
Material Changes
No material financial changes or operational updates are detailed within the body of this filing. The only reported event is the dissemination of the Corporate Presentation to investors.
Guidance, Outlook, and Risks
Management Commentary: The Company posted a presentation to update investors on its business and products.
Legal Disclaimer: The information in this report is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it subject to the liabilities of that section. It shall not be incorporated by reference into other filings unless expressly set forth by specific reference.
Risks/Contingencies: No specific risks or contingencies are listed in this filing text.
Key Facts for Investor Verification
- Verify the contents of the attached "Corporate Presentation" (Exhibit 99.1) for actual business updates and product status.
- Confirm that the presentation is accessible via the "Investors" section of the Company's website (www.capricor.com).
- Note that this 8-K filing itself contains no audited financial statements or specific numerical guidance.